What’s to Come for Medicare: Impacts of the Inflation Reduction Act
A session at the 2024 AMCP Nexus focused on the successes and challenges stakeholders are experiencing as they prepare for calendar year 2025 Medicare...
Dynamic Oncology Pipeline Continues to See Growth, New Treatment Modalities
The oncology pipeline has continually expanded over the past decade, currently representing 38% of the agents in active development. Global spending on cancer drugs...
The 2024 Election Is Weeks Away: What Will Be the Impact on Health Policy?
With the 2024 election just a few weeks after the 2024 AMCP Nexus, a session addressed how control of the White House and Congress...
Impact of GLP-1 Agonists for Weight Loss and Health Plan Implications
The use of GLP-1 agonists for weight management has substantially increased in recent years, creating considerable challenges for both employers and insurers offering coverage...